Panchsheel Organics Ltd
Incorporated in 1990, Panchsheel Organics Ltd is a manufacturer of Bulk Drug and Intermediate[1]
- Market Cap ₹ Cr.
- Current Price ₹
- High / Low ₹ /
- Stock P/E
- Book Value ₹
- Dividend Yield %
- ROCE %
- ROE %
- Face Value ₹
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals
Quarterly Results
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Dividend Payout % |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Figures in Rs. Crores
| Equity Capital |
| Reserves |
| Total Liabilities |
| CWIP |
| Investments |
| Total Assets |
Cash Flows
Figures in Rs. Crores
| Net Cash Flow |
| Free Cash Flow |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit |
Ratios
| Debtor Days |
| Inventory Days |
| Days Payable |
| Cash Conversion Cycle |
| Working Capital Days |
| ROCE % |
Insights
In beta| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Electricity Consumption per kg of production units/kg ・Standalone data |
|
|||||||||
| Gas/Furnace Oil Consumption per kg of production liters/kg ・Standalone data |
||||||||||
| Total Electricity Consumed units ・Standalone data |
||||||||||
| Total Gas/Furnace Oil Consumed liters ・Standalone data |
||||||||||
| Export Sales Rs. lakhs ・Standalone data |
||||||||||
| Foreign Exchange Earnings Rs. lakhs ・Standalone data |
||||||||||
| Number of Permanent Employees employees ・Standalone data |
||||||||||
| Manufacturing Area (Constructed) sq.mt ・Standalone data |
||||||||||
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Meeting Updates
- Board approved applying for NSE Main Board direct listing of entire paid-up equity capital.
-
Announcement Under Regulation-30 Of SEBI(LODR), 2015 With Respect To Application For National Stock Exchange (NSE) Listing Of Company.
- Board approved application for NSE Main Board direct listing on October 24, 2026.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Certificate under Regulation-74(5) of SEBI (DP) Regulations, 2018 for the quarter and half year ended 30th September 2026.
-
Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s
- AGM approved reappointment of Rajesh Turakhia, regularized Chandan Turakhia, named Kishor Turakhia Managing Director, appointed auditor for five years.
-
Announcement under Regulation 30 (LODR)-Change in Management
- AGM approved reappointment of Rajesh Turakhia, Chandan Turakhia regularization, Kishor Turakhia as Managing Director, and auditor appointment for five years.
Annual reports
-
Annual Report 2026
from bse
-
Annual Report 2025
from bse
-
Annual Report 2024
from bse
-
Annual Report 2023
from bse
-
Annual Report 2022
from bse
-
Annual Report 2021
from bse
-
Annual Report 2020
from bse
-
Annual Report 2019
from bse
-
Annual Report 2018
from bse
-
Annual Report 2017
from bse
-
Annual Report 2016
from bse
-
Annual Report 2015
from bse
-
Annual Report 2014
from bse
-
Annual Report 2013
from bse
-
Annual Report 2012
from bse
Business Overview:[1][2]
Panchsheel Organics Ltd, promoted by the Turakhia Bros Group, manufactures and exports active pharmaceutical ingredients (APIs), intermediates, human and veterinary formulations, nutraceuticals, vitamins, hormones, steroids and specialty chemicals. The company also operates in agri-biotechnology products, aquaculture and dehydrated culture media, with manufacturing processes stated to comply with GMP and WHO standards.